Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MOXIDECTIN INJECTIO

Closed
SPE2DP-26-T-3583Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Moxidectin Injection, a veterinary product indicated for use in dogs 12 months of age and older, is being procured under solicitation SPE2DP-26-T-3583 with a quantity of 10 kits, each containing a 10 mL vial of moxidectin microspheres at a concentration of 10 mg/mL after constitution, along with one 8 mL vial of sterile vehicle and one vent needle for subcutaneous administration only. The item is regulated by the FDA, and the manufacturer is Fisher Scientific Company L.L.C. with part number R061414, also listed under Thermo Fisher Scientific Chemicals. The product must be stored unconstituted at or below 25°C and protected from prolonged light exposure; once constituted, it remains stable for eight weeks under refrigeration at 2–8°C. A non-extendable shelf life of 24 months applies, as required under RS001 for a TYPE I (CODE M) item. Packaging and marking must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, with palletization following RP001: DLA Packaging Requirements for Procurement and packaging data compliant with MIL-STD-2073-1E. Each unit must be sealed in commercial-grade containers that ensure protection from damage and meet safe transportation standards for common carriers at the lowest rate. Delivery is FOB destination to the U.S. Army Medical Materiel Center in Korea, with an 89-day delivery window from order placement and a required delivery date of May 28, 2026. The contract is governed by the Department of Defense and administered by DLA Troop Support under a Simplified Acquisition framework, with automated award anticipated. The contractor must comply with all Federal Acquisition Regulation clauses covering cybersecurity, including safeguarding covered defense information and cyber incident reporting, as well as requirements related to whistleblower rights, disclosure of information, prohibition on covered telecommunications equipment, and combating trafficking in persons. Invoicing and payment must be processed via the Wide Area Workflow system, and the vendor must maintain current registration in the System for Award Management with accurate representations regarding small business status, exclusions, and socioeconomic classifications. The product is subject to the Berry Amendment and Buy American Act provisions, and the contract includes special requirements for hazardous materials identification and NIST SP 800-171 assessment compliance. Inspection and acceptance occur at

General Info

Supply of 10 Moxidectin Injection kits for dogs, shipped to Korea within 89 days, FDA compliant.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

456199 - All Other Health and Personal Care RetailersView NAICS

Place of Performance

UNIT 15479, APO, AP, 96260-5479, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3583 Medical Supply Chain Pharma

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
MOXIDECTIN INJECTIO
MOXIDECTIN INJECTION, VETERINARY
.
INDICATED FOR USE IN DOGS 12 MONTHS OF AGE AND OLDER.
10ML VIAL; BOX INCLUDES 1 VIAL 10% (889MG/VIAL)
MOXIDECTIN MICROSPERES (10MG/ML AFTER CONSTITUTION),
1 8ML VIAL OF STERILE VEHICLE, 1 VENT NEEDLE.
FOR SUBCUTANEOUS USE ONLY.
.
UNIT OF ISSUE: KIT (KT)
.
STORE UNCONSTITUTED AT OR BELOW 25DEG C (77DEG F)/ DO NOT EXPOSE TO
LIGHT FOR EXTENDED PERIODS OF TIME, AFTER CONSTITUTION PRODUCCT IS
STABLE FOR 8 WEEKS STORED UNDER REFRIGERATION AT
2-8 DEG C (36-46 DEG F);
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
FISHER SCIENTIFIC COMPANY L.L.C. 22527 P/N R061414 THERMO FISHER SCIENTIFIC CHEMICALS, 3LRY4 P/N R061414
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments%
SPE2DP-26-T-3583
SECTION B
PR: 7016965205 PRLI: 0001 CONT’D
2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016965205 0001 KT 10.000
NSN/MATERIAL:6509017329125
DELIVERY (IN DAYS):0089
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
WT4J8S
SPE2DP-26-T-3583
SECTION B
PR: 7016965205 PRLI: 0001 CONT’D
W6R1 USA MED MATERIEL CTR KORE
UNIT 15479
APO AP 96260-5479
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WT4J8S
W6R1 USA MED MATERIEL CTR KORE
BLDG 709 CAMP CARROLL
WAEGWAN 39886
KR
Need Ship Date:00/00/0000 Original Required Delivery Date:05/28/2026
SPE2DP-26-T-3583 NSN/Part Number: 6509-01-732-9125 Quantity: 10 KT Purchase Request: 7016965205QTY: 10 Delivery: 89 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS